Olink Holding AB (publ) Operating Income 2020-2023 | OLK

Olink Holding AB (publ) operating income from 2020 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Olink Holding AB (publ) Annual Operating Income
(Millions of US $)
2023 $-50
2022 $-31
2021 $-45
2020 $-5
2019 $-11
Olink Holding AB (publ) Quarterly Operating Income
(Millions of US $)
2023-12-31 $-6
2023-09-30 $-8
2023-06-30 $-19
2023-03-31 $-17
2022-12-31 $8
2022-09-30 $-8
2022-06-30 $-15
2022-03-31 $-16
2021-12-31 $-8
2021-09-30 $-12
2021-06-30 $-11
2021-03-31 $-14
2020-12-31 $5
2020-09-30 $-1
2020-06-30 $-5
2020-03-31 $-5
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.864B $0.170B
Olink Holding AB provides a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic institutions to deepen the understanding of real-time human biology. It operates principally in Europe, North America and Asia. Olink Holding AB is headquartered in Uppsala, Sweden.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $34.790B 19.11
Inspire Medical Systems (INSP) United States $7.322B 0.00
10x Genomics (TXG) United States $3.489B 0.00
IRhythm Technologies (IRTC) United States $3.410B 0.00
Axonics (AXNX) United States $3.396B 0.00
Enovis (ENOV) United States $3.029B 23.01
Azenta (AZTA) United States $2.925B 238.46
Hims & Hers Health (HIMS) United States $2.685B 0.00
Privia Health (PRVA) United States $2.183B 96.84
Schrodinger (SDGR) United States $1.763B 0.00
Omnicell (OMCL) United States $1.231B 30.12
Phreesia (PHR) United States $1.169B 0.00
Definitive Healthcare (DH) United States $0.817B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.783B 0.00
Standard BioTools (LAB) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.608B 0.00
Talkspace (TALK) United States $0.519B 0.00
Health Catalyst (HCAT) United States $0.367B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.333B 0.00
Clover Health Investments (CLOV) United States $0.312B 0.00
Pulmonx (LUNG) United States $0.293B 0.00
P3 Health Partners (PIII) United States $0.170B 0.00
Butterfly Network (BFLY) United States $0.162B 0.00
American Well (AMWL) United States $0.148B 0.00
MSP Recovery (LIFW) United States $0.139B 0.00
Augmedix (AUGX) United States $0.133B 0.00
Outset Medical (OM) United States $0.131B 0.00
TruBridge (TBRG) United States $0.116B 4.94
111 (YI) China $0.087B 0.00
Future Health ESG (FHLT) United States $0.073B 0.00
SHL Telemedicine (SHLT) Israel $0.071B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.047B 0.00
Movano (MOVE) United States $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.025B 0.00
Cue Health (HLTH) United States $0.022B 0.00
CareCloud (CCLD) United States $0.018B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00